A new study aimed at assessing the efficacy of THC-based medications for sufferers of cachexia was launched this week by Applied Cannabis Research (ACR), a division of Southern Cannabis Holdings (SCH).
Read more:
Vaping laws changed in Australia on 1st October 2021, making nicotine-containing vape liquid a Schedule 4 prescription-only medicine.
Applied Cannabis Research welcomes PM Scott Morrison’s announcement of a Royal Commission into suicide among Australia’s veterans and serving Defence personnel. We
Aruma Labs teams up with Applied Cannabis Research for endometriosis observational study Applied Cannabis Research is pleased to announce Aruma Labs (Aruma)
© 2022 All rights reserved, Applied Cannabis Research
